Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Summary by ajmc.com
These findings support the potential role of ctDNA in prognostic assessment and early intervention.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

2 Articles

ajmc.comajmc.com

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

These findings support the potential role of ctDNA in prognostic assessment and early intervention.

Read Full Article
European Medical JournalEuropean Medical Journal

ctDNA Levels Predict Treatment Response in Breast Cancer

ctDNA levels at baseline and during treatment predict response and progression free survival in advanced breast cancer, supporting ctDNA as a surrogate endpoint for targeted therapy outcomes.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

European Medical Journal broke the news in on Sunday, January 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Breast Cancer icon

Breast Cancer

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal